Biodyne Co Ltd
KOSDAQ:314930
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8 290
22 800
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Biodyne Co Ltd
Total Receivables
Biodyne Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
B
|
Biodyne Co Ltd
KOSDAQ:314930
|
Total Receivables
₩754.2m
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Dentium Co Ltd
KRX:145720
|
Total Receivables
₩147.4B
|
CAGR 3-Years
20%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Total Receivables
₩60.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
5%
|
CAGR 10-Years
9%
|
|
|
J
|
Jeisys Medical Inc
KOSDAQ:287410
|
Total Receivables
₩16.1B
|
CAGR 3-Years
38%
|
CAGR 5-Years
240%
|
CAGR 10-Years
N/A
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Total Receivables
₩32.3B
|
CAGR 3-Years
102%
|
CAGR 5-Years
48%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lutronic Corp
KOSDAQ:085370
|
Total Receivables
₩47.2B
|
CAGR 3-Years
43%
|
CAGR 5-Years
27%
|
CAGR 10-Years
22%
|
|
Biodyne Co Ltd
Glance View
Biodyne Co., Ltd. engages in the development of cancer diagnosis solutions. The company is headquartered in Seoul, Seoul and currently employs 26 full-time employees. The company went IPO on 2021-03-17. The firm produces and sells LBC diagnostic equipment and diagnostic reagent kits. The firm's LBC equipment include PATHPLORER AUTO, PATHPLORER 4.7, PATHPLORER 4.63 and PATHPLORER ECO. The firm sells its products in domestic and overseas markets such as Japan, Russia, Portugal and Thailand.
See Also
What is Biodyne Co Ltd's Total Receivables?
Total Receivables
754.2m
KRW
Based on the financial report for Dec 31, 2023, Biodyne Co Ltd's Total Receivables amounts to 754.2m KRW.
What is Biodyne Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
-17%
Over the last year, the Total Receivables growth was 25%. The average annual Total Receivables growth rates for Biodyne Co Ltd have been -21% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
